A large real-world cohort study published in JAMA Network Open followed over 18,000 propensity-matched adults and found that those taking tirzepatide were significantly more likely to achieve 5%, 10%, or 15% weight loss within one year compared to those taking semaglutide
The brand states it currently offers services in all 50 states plus Washington, D.C., while noting some services may not be available in every state and are subject to change
If you're still in titration (increasing doses weekly or bi-weekly), you haven't yet reached the dose needed for full effect
Short answer: yes, when used in a balanced way
GB, AG, EM, ER, PA, and GI critically reviewed the literature and drafted the manuscript
Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources